Applications including "Anticancer drug"
-
GA416 - Analysis of Busulfan (Under the Condition of USP-PF, Busulfan Tablets, ASSAY) -
GC InertSearch InertCap 5 -
GA404 - Analysis of Busulfan (Under the Condition of the draft for USP PF52(2), Busulfan, ORGANIC IMPURITIES) -
GC InertSearch InertCap 5 -
GA403 - Analysis of Busulfan (Under the Condition of the draft for USP PF52(2), Busulfan, ASSAY) -
GC InertSearch InertCap 5 -
LC149 - Analysis of Olaparib (Under the Condition of draft for USP PF51(6), Olaparib Tablets, DISSOLUTION) -
LC InertSearch InertSustain C18 -
LC136 - Analysis of Olaparib (Under the Condition of draft for USP PF51(6), Olaparib Tablets, ASSAY) -
LC InertSearch InertSustain C18 -
LC129 - Analysis of Olaparib (Under the Condition of draft for USP, Olaparib, ASSAY) -
LC InertSearch Inertsil Hybrid-C18 -
LB883 - Analysis of Paclitaxel -
LC InertSearch InertSustain PFP -
LB676 - Analysis of Anticancer drug and related substances -
LC InertSearch InertSustain PFP HP

















